Literature DB >> 22101838

Assessing cellular toxicities in fibroblasts upon exposure to lipid-based nanoparticles: a high content analysis approach.

Leonardo J Solmesky1, Michal Shuman, Meir Goldsmith, Miguel Weil, Dan Peer.   

Abstract

Lipid-based nanoparticles (LNPs) are widely used for the delivery of drugs and nucleic acids. Although most of them are considered safe, there is confusing evidence in the literature regarding their potential cellular toxicities. Moreover, little is known about the recovery process cells undergo after a cytotoxic insult. We have previously studied the systemic effects of common LNPs with different surface charge (cationic, anionic, neutral) and revealed that positively charged LNPs ((+)LNPs) activate pro-inflammatory cytokines and induce interferon response by acting as an agonist of Toll-like receptor 4 on immune cells. In this study, we focused on the response of human fibroblasts exposed to LNPs and their cellular recovery process. To this end, we used image-based high content analysis (HCA). Using this strategy, we were able to show simultaneously, in several intracellular parameters, that fibroblasts can recover from the cytotoxic effects of (+)LNPs. The use of HCA opens new avenues in understanding cellular response and nanotoxicity and may become a valuable tool for screening safe materials for drug delivery and tissue engineering.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101838     DOI: 10.1088/0957-4484/22/49/494016

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  7 in total

1.  Convergence of Highly Resolved and Rapid Screening Platforms with Dynamically Engineered, Cell Phenotype-Prescriptive Biomaterials.

Authors:  Neal K Bennett; Anandika Dhaliwal; Prabhas V Moghe
Journal:  Curr Pharmacol Rep       Date:  2016-03-18

2.  A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease.

Authors:  Leonardo J Solmesky; Netaly Khazanov; Hanoch Senderowitz; Peixiang Wang; Berge A Minassian; Igor M Ferreira; Wyatt W Yue; Alexander Lossos; Miguel Weil; Or Kakhlon
Journal:  Biochem J       Date:  2017-09-28       Impact factor: 3.857

3.  Local Delivery of Ox40l, Cd80, and Cd86 mRNA Kindles Global Anticancer Immunity.

Authors:  Ole Audun Werner Haabeth; Timothy R Blake; Colin J McKinlay; Anders A Tveita; Adrienne Sallets; Robert M Waymouth; Paul A Wender; Ronald Levy
Journal:  Cancer Res       Date:  2019-01-28       Impact factor: 12.701

4.  Radiofrequency treatment alters cancer cell phenotype.

Authors:  Matthew J Ware; Sophia Tinger; Kevin L Colbert; Stuart J Corr; Paul Rees; Nadezhda Koshkina; Steven Curley; H D Summers; Biana Godin
Journal:  Sci Rep       Date:  2015-07-13       Impact factor: 4.379

Review 5.  Noncoding RNAs in cancer therapy resistance and targeted drug development.

Authors:  Wen-Tao Wang; Cai Han; Yu-Meng Sun; Tian-Qi Chen; Yue-Qin Chen
Journal:  J Hematol Oncol       Date:  2019-06-07       Impact factor: 17.388

Review 6.  Properties and prospects of adjuvants in influenza vaccination - messy precipitates or blessed opportunities?

Authors:  Babak Jalilian; Stig Hill Christiansen; Halldór Bjarki Einarsson; Mehdi Rasoli Pirozyan; Eskild Petersen; Thomas Vorup-Jensen
Journal:  Mol Cell Ther       Date:  2013-11-06

Review 7.  Harnessing RNAi nanomedicine for precision therapy.

Authors:  Dan Peer
Journal:  Mol Cell Ther       Date:  2014-02-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.